# HCW Biologics Inc.: Form 8-K, filed Mar 2, 2026

- Company: [HCW Biologics Inc.](/companies/hcwb.md) (CIK 1828673)
- Form: 8-K
- Filed: 2026-03-02
- Accepted by EDGAR: Mar 2, 2026, 08:08 ET
- Period: 2026-02-26
- Accession: 0001193125-26-084291
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1828673/000119312526084291/hcwb-20260226.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1828673/000119312526084291/

## Items reported

- Item 3.01: Delisting notice
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1828673/000119312526084291/hcwb-20260226.htm

Filed Mar 2, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-084291. Last ingested by Listed: Nov 5, 2026, 12:33 ET. No prices; not investment advice.
